Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Terminated1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT01187810Phase 1Terminated
Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHL
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaNon-Hodgkin's Lymphoma
Studydirector

Research Network

Collaboration Network

6 collaborators·11 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Texas Tech University Health Sciences Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Barry J Maurer, MD, PhD

Texas Tech University Health Sciences Center

Moderately Similar
2 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteLymphoma, Non-Hodgkin

Worked with same sponsors:

South Plains Oncology Consortium
Collaborated on 1 trial
Similarity Score34%

Min Kang, PharmD

Texas Tech University Health Sciences Center

Moderately Similar
1 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteLymphoma, Non-Hodgkin

Worked with same sponsors:

South Plains Oncology Consortium
Collaborated on 1 trial
Similarity Score34%

Anna R Franklin, MD

M.D. Anderson Cancer Center

Moderately Similar
1 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteLymphoma, Non-Hodgkin

Worked with same sponsors:

South Plains Oncology Consortium
Collaborated on 1 trial
Similarity Score34%

Patrick Reynolds, MD, PhD

Texas Tech University Health Sciences Center

Moderately Similar
1 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteLymphoma, Non-Hodgkin

Worked with same sponsors:

South Plains Oncology Consortium
Collaborated on 1 trial
Similarity Score34%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Moderately Similar
24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaLymphoma, Non-Hodgkin
Similarity Score30%

Yves Beguin, MD, PhD

CHU-ULg

Moderately Similar
7 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteLymphoma, Non-Hodgkin
Similarity Score30%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, Acute
Similarity Score20%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, Acute
Similarity Score20%

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, Acute
Similarity Score20%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score20%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01187810Phase 1StudyDirector

Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHL

Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaNon-Hodgkin's Lymphoma
Terminated

All 1 trials loaded